张超
【摘 要】目的:观察参麦注射液联合多巴胺治疗高原性心脏病的临床疗效,探讨其临床应用价值。方法:选取我院心内科自2011年6月至2016年5月收治的72例高原性心脏病患者,采取随机分组其中观察组36例,对照组36例,观察组在常规治疗的基础上采取参麦注射液联合多巴胺进行治疗,对照组采取常规治疗,观察比较两组患者的总体治疗有效率和NYHA心力衰竭的分级,以及两组患者在治疗前后心率和左心室射血分数。结果:经治疗观察组NYHA心力衰竭分级低于对照组,观察组心率减慢程度好于对照组,左心室射血分数也比对照组明显增高,观察组治疗后对患者心脏功能的改善明显高于对照组,差异有统计学意义( p<0.05)。观察组总体治疗有效率为97.22%,高于对照组的84.51%,差异有统计学意义( p<0.05)。结论:参麦注射液联合多巴胺治疗高原性心脏病临床效果好,负面作用少,可以明显改善患者的心脏功能,值得临床应用加以推广。
【关键词】参麦注射液;多巴胺;高原性心脏病; 临床疗效
Abstract Objective: to observe the clinical effect of Shenmai injection combined with dopamine in the treatment of high altitude heart disease. Methods: from June 2011 to May 2016, 72 patients with high altitude heart disease in our hospital were randomly divided into observation group (n = 36) and control group (n = 36). 36 cases in the control group were treated with Shenmai injection combined with dopamine on the basis of routine treatment, while the control group was treated with routine therapy. The overall effective rate of treatment and the classification of NYHA heart failure, before and after treatment of heart rate and left ventricular ejection fraction before and after treatment were observed and compared between the two groups. Results:The NYHA grade of heart failure in the observation group was lower than that in the control group, and the heart rate in the observation group was slower than that in the control group, besides the left ventricular ejection fraction was significantly higher than that in the control group. The improvement of heart function in the observation group was significantly higher than that in the control group (p < 0.05). The overall effective rate of the observation group was 97.22%. The difference was statistically significant (p < 0.05). Conclusion: Shenmai injection combined with dopamine in the treatment of high altitude heart disease has good clinical effect and less negative effect. It can obviously improve the heart function of the patients, and it is worthy to popularize in clinical application.
Key words: Shenmai injection; dopamine; high altitude heart disease; clinical efficacy
【中圖分类号】 R541.3
【文献标识码】 A
【文章编号】 1672-3783(2018)04-03-005-01
高原性心脏病 (High Altitude Heart Disease),是由于长期生活在高原地区,或者由低海拔地区转入高原地区生活后出现的一种心脏疾病[1]。主要以慢性低压缺氧引起的肺动脉高压现象,从而引起心机缺氧,导致右心室肥厚或右心功能不全,严重时会出现心力衰竭现象。临床上一般分为儿童高原心脏病和成人高原心脏病。在我国近几年患病率成上升趋势,一般发病在春、冬两季,在我国男性发病率高于女性,而且海拔越高的地区发病率也越高[2]。目前在全球临床上并没有十分有效的药物,这也导致了高原性心脏病,难以根治,长期反复。本文对我院心内科自2011年6月至2016年5月……